| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.28 | 0.09 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.24 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |